As an example, untargeted liposomes were used to co-deliver an anti-VEGF siRNA and etoposide and caused a significant inhibition of tumor growth in an orthotopic non-small cell lung cancer model compared to the combinations of either free drugs or the separate liposomal formulations [282]. The gene discussed is VEGFA; the disease is neoplasm.